Merck Cements Lead In Lung Cancer With Bristol Myers Fizzling

Immuno-oncology is Merck & Co's (NYSE ... approve Keytruda on a smaller phase II study. Squandering a lead The first-line lung cancer space was thrown wide open last last summer when Bristol-Myers Squibb's Opdivo failed to beat chemo in the hotly awaited ...

Source : https://seekingalpha.com/article/4072740-merck-cements-lung-cancer-lead

104
Merck Cements Lead In Lung Cancer With Bristol Myers Fizzling

Source:Forbes

Merck Cements Lead In Lung Cancer With Bristol Myers Fizzling